hVIVO plc

hVIVO plc is a full-service early specialist contract research organisation operating in the United Kingdom, Europe, and North America. It provides end-to-end early clinical development services to the biopharmaceutical industry, including phase I capabilities and human challenge trial services. The company tests vaccines and antivirals using human challenge clinical trials and offers laboratory services such as virology, immunology, biomarker analysis, assay development, sample analysis, and data interpretation. It also provides preclinical and early clinical research, sales and marketing, data management, storage, statistics, and drug development consultancy. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. It is headquartered in London, the United Kingdom.